---
title: "GATA2"
date: 2023-05-13 00:00:00
layout: post
categories: Gene
summary: "## Information about Gene GATA2:"
tags: ['GATA2', 'HematologicalDisorders', 'TranscriptionFactor', 'Mutation', 'Treatment', 'Prognosis', 'Immunodeficiency', 'Lymphedema']
---

## Information about Gene GATA2:

### Pathology
The GATA binding protein 2 (GATA2) gene encodes a transcription factor that is implicated in hematopoiesis and lymphangiogenesis. GATA2 mutations have been identified in a variety of hematological disorders, including myelodysplastic syndrome (MDS), acute myeloid leukemia (AML), and familial myelodysplasia and leukemia syndrome (FML), among others.

### Function
GATA2 is a transcription factor and has a key role in the differentiation and survival of hematopoietic stem and progenitor cells. In addition, GATA2 controls the normal development and maintenance of lymphatic vessels.

### External IDs and Aliases
- HGNC: 4175
- Ensembl: ENSG00000125845
- NCBI Entrez Gene: 2624
- OMIM: 137295
- UniProtKB/Swiss-Prot: P23733
- Aliases: EBM1, DCML, IMD21, MGC2018

### AA mutation list and mutation type with dbSNP ID
- c.1061C>T (p.Arg354Cys); rs193922992
- c.1063T>C (p.Leu355Pro); rs768436143
- c.1065G>T (p.Cys355Phe); rs193922994

### Somatic SNVs/InDels with dbSNP ID
- rs139934308: G>A substitution; Pathogenic; AML
- rs141942196: G>A substitution; Pathogenic; MDS

### Related disease
GATA2 mutations are associated with a variety of hematological disorders, including MDS, AML, and FML. Additionally, GATA2 deficiency syndrome is a rare disorder that can cause a wide range of symptoms, including immunodeficiency, lymphedema, and susceptibility to infections.

### Treatment and Prognosis
Treatment for hematological disorders associated with GATA2 mutations varies depending on the specific disease and the patient. In some cases, bone marrow transplantation may be recommended. The prognosis for patients with GATA2 mutations also varies widely depending on the individual case.

### Drug response
There is limited information available regarding drug response in patients with GATA2 mutations, and further research is needed in this area.

### Related papers
- Subject: GATA2 mutations in hematological disorders
- Author: Hahn CN, Scott HS
- DOI: 10.1007/s00277-016-2809-6

- Subject: GATA2 deficiency syndrome: a review
- Author: Dickinson RE, Griffin H, Bigley V
- DOI: 10.3389/fimmu.2018.00546

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**